compounded semaglutide being discontinued for weight loss | Blog semaglutide being pulled from market

Sadly, most people arent getting that guidance from an MD or RD, says Grunvald

The goal is to use enough medication to support meaningful clinical improvement while preserving nutrition, muscle, function, and long-term adherence

The trial design included a rigorous oversight process, with approval from relevant institutional review boards and adherence to Good Clinical Practice guidelines

Maintaining detailed records of symptoms, timing, and severity helps identify patterns and optimize protocols

This makes retatrutide the first triple-receptor agonist to reach late-stage clinical trials, representing the next step in the evolution of incretin-based metabolic research compounds

doi: 10.1016/S0140-6736(64)90011-X 6 BaggioLLDruckerDJ